A new phase of trials to test two promising HIV vaccines began last week in London and Oxford. The vaccines—one made of naked DNA, the other a weakened pox virus—contain genes from a common strain of HIV in Africa, and should provoke an immune response that fends off the virus itself. Volunteers are receiving different combinations of the vaccines or a placebo. Teams at Imperial College in London and the Medical Research Council’s Human Immunology Unit in Oxford hope to recruit 120 volunteers aged 18 to 60, who must be HIV-negative.
More from New Scientist
Explore the latest news, articles and features
Technology
Test moderators use AI-generated writing to judge literacy standards
News
Mind
THC in cannabis may reduce nightmares in people with PTSD
News
Environment
Fishers detonate a bomb every hour on one Indonesian coral reef
News
Environment
How bad is the UK drought and how long will it continue?
News
Popular articles
Trending New Scientist articles